143 related articles for article (PubMed ID: 6099595)
1. GABAergic and opioid regulation of the substantia nigra innominata-cortical cholinergic pathway in the rat.
Wood PL; McQuade PS; Nair NP
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):789-92. PubMed ID: 6099595
[TBL] [Abstract][Full Text] [Related]
2. GABAergic control of the cholinergic projections to the frontal cortex is not tonic.
Blaker WD
Brain Res; 1985 Jan; 325(1-2):389-90. PubMed ID: 3978431
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular evidence for a GABAergic modulation of the cholinergic vasodilatatory basalocortical system in the rat.
Barbelivien A; Noël C; MacKenzie ET; Dauphin F
Brain Res; 1999 Jul; 834(1-2):223-7. PubMed ID: 10407121
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes.
Robbins TW; Everitt BJ; Marston HM; Wilkinson J; Jones GH; Page KJ
Behav Brain Res; 1989 Dec; 35(3):221-40. PubMed ID: 2688683
[TBL] [Abstract][Full Text] [Related]
5. The substantia innominata remains incognita: pressing research themes on basal forebrain neuroanatomy.
Sarter M
Brain Struct Funct; 2008 Sep; 213(1-2):11-5. PubMed ID: 18183419
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological manipulations of the substantia innominata-cortical cholinergic pathway.
Wenk GL
Neurosci Lett; 1984 Sep; 51(1):99-103. PubMed ID: 6151154
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of GABAergic and glutamatergic inputs to the nucleus basalis--cortical and the septal-hippocampal cholinergic projections.
Wood PL
Can J Physiol Pharmacol; 1986 Mar; 64(3):325-8. PubMed ID: 3708440
[TBL] [Abstract][Full Text] [Related]
8. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice.
Durkin TP
Behav Brain Res; 1992 Sep; 50(1-2):155-65. PubMed ID: 1333220
[TBL] [Abstract][Full Text] [Related]
9. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
10. Effects of lesions in the substantia innominata on active avoidance task and cerebral glucose metabolism.
Mihara B
Keio J Med; 1989 Dec; 38(4):419-31. PubMed ID: 2630780
[TBL] [Abstract][Full Text] [Related]
11. Suppression of amygdala-kindled seizure in cats by enhanced GABAergic transmission in the substantia innominata.
Morita K; Okamoto M; Seki K; Wada JA
Exp Neurol; 1985 Jul; 89(1):225-36. PubMed ID: 2988991
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways.
Barbelivien A; Bertrand N; Besret L; Beley A; MacKenzie ET; Dauphin F
Brain Res; 1999 Sep; 840(1-2):115-24. PubMed ID: 10517959
[TBL] [Abstract][Full Text] [Related]
13. [Role of catecholamines in regulating motor functions (review)].
Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1068-74. PubMed ID: 2863909
[No Abstract] [Full Text] [Related]
14. A glutamatergic innervation of the nucleus basalis/substantia innominata.
Davies SW; McBean GJ; Roberts PJ
Neurosci Lett; 1984 Mar; 45(1):105-10. PubMed ID: 6328369
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of cortical somatostatin and monoamine levels in the rat does not require intact cholinergic innervation.
Fine A; Pittaway K; de Quidt M; Czudek C; Reynolds GP
Brain Res; 1987 Mar; 406(1-2):326-9. PubMed ID: 2436718
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic input to cholinergic neurons in the substantia innominata and nucleus basalis magnocellularis in the rat.
Gasbarri A; Sulli A; Pacitti C; McGaugh JL
Neuroscience; 1999; 91(3):1129-42. PubMed ID: 10391489
[TBL] [Abstract][Full Text] [Related]
17. GABAergic regulation of the substantia innominata-cortical cholinergic pathway.
Wood PL; Richard J
Neuropharmacology; 1982 Oct; 21(10):969-72. PubMed ID: 6292769
[TBL] [Abstract][Full Text] [Related]
18. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat.
Evenden JL; Marston HM; Jones GH; Giardini V; Lenard L; Everitt BJ; Robbins TW
Behav Brain Res; 1989 Mar; 32(2):129-49. PubMed ID: 2923657
[TBL] [Abstract][Full Text] [Related]
19. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens.
Swerdlow NR; Swanson LW; Koob GF
Brain Res; 1984 Jul; 306(1-2):141-8. PubMed ID: 6087974
[TBL] [Abstract][Full Text] [Related]
20. GABAergic axons in the ventral forebrain of the rat: an electron microscopic study.
Chang HT; Tian Q; Herron P
Neuroscience; 1995 Sep; 68(1):207-20. PubMed ID: 7477926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
